Shailender Bhatia, MD – University of Washington
Petros Grivas, MD, PhD – University of Washington
Click here for more detailed CME, CNE, CPE and MOC information and program objectives.Presentations include time for Audience Response System (ARS)-assisted audience interaction as well as general question and answer time.
Session I: Introduction to Cancer Immunotherapy
Welcome, Introduction, SITC Resources
Basic Principles of Cancer Immunotherapy
Session II: Immunotherapy in Practice
Immunotherapy for the Treatment of Skin Cancers
Immunotherapy for the Treatment of Lung Cancer
Immunotherapy for the Treatment of Head and Neck Cancers
Immunotherapy for the Treatment of Genitourinary Malignancies
Immunotherapy for the Treatment of Hematologic Malignancies
Immunotherapy for the Treatment of Additional Solid Tumors: Hepatocellular
Session III: Immunotherapy Challenges and Beyond
11:30 a.m.–12:05 p.m.
Practical Barriers in Cancer Immunotherapy Treatment
What's next for cancer immunotherapy?
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:
Participation in this free, CME-, CPE-, CNE- and MOC-certified online pre-program course is strongly recommended as it contains information that will not be covered at the program. This updated, interactive course provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program.Click here to access the course.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com